(Reuters) -R1 RCM said on Thursday private-equity firms TowerBrook Capital Partners and Clayton, Dubilier & Rice (CD&R) would acquire the healthcare technology company in a deal that values it at $8.9 ...
DuvaSawko, a physician-owned and operated revenue cycle management company, is being recapitalized by Ancor Capital Partners. DuvaSawko, predominantly serves independent emergency physician groups and ...
Zacks Investment Research on MSN
RCM Technologies, Inc. (RCMT) stock dips while market gains: Key facts
In the latest close session, RCM Technologies, Inc. (RCMT) was down 1.72% at $20.30. The stock's performance was behind the S&P 500's daily gain of 0.55%. Elsewhere, the Dow gained 0.63%, while the ...
In a report released today, Daniel Grosslight from Citi downgraded R1 RCM (RCM – Research Report) to a Hold, with a price target of $14.30. Daniel Grosslight has given his Hold rating due to a ...
Analyst Craig Hettenbach from Morgan Stanley reiterated a Buy rating on R1 RCM (RCM – Research Report) and keeping the price target at $17.00. Craig Hettenbach has given his Buy rating due to a ...
To get a sense of who is truly in control of R1 RCM Inc. (NASDAQ:RCM), it is important to understand the ownership structure of the business. The group holding the most number of shares in the company ...
R1 RCM supports healthcare companies with technology-driven billing services. It saw revenue rise by 31% year over year in the third quarter, but net income fell. The company purchased Cloudmed in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results